Edwards Lifesciences retained earnings (accumulated deficit) for the quarter ending September 30, 2024 were $12.781B, a 48.23% increase year-over-year.
Edwards Lifesciences retained earnings (accumulated deficit) for 2023 were $8.992B, a 18.48% increase from 2022.
Edwards Lifesciences retained earnings (accumulated deficit) for 2022 were $7.59B, a 25.08% increase from 2021.
Edwards Lifesciences retained earnings (accumulated deficit) for 2021 were $6.068B, a 32.93% increase from 2020.
Edwards Lifesciences Retained Earnings (Accumulated Deficit) 2010-2024 | EW